Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,611 | -52,287 | N/A | N/A | -36,144 |
| Depreciation Amortization | 464 | 347 | N/A | N/A | 449 |
| Other Working Capital | 3,321 | 1,517 | N/A | N/A | 2,245 |
| Other Operating Activity | 36,838 | 23,820 | 0 | 0 | 4,216 |
| Operating Cash Flow | $-36,988 | $-26,603 | $N/A | $N/A | $-29,234 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -4,500 |
| PPE Investments | -178 | N/A | N/A | N/A | -116 |
| Purchase Of Investment | -451,994 | -95,761 | N/A | N/A | -183,765 |
| Sale Of Investment | 147,065 | 94,388 | N/A | N/A | 77,844 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -35 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -35 |
| Investing Cash Flow | $-305,107 | $-1,373 | $N/A | $N/A | $-110,572 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 546,209 | 34,867 | N/A | N/A | 83,201 |
| Other Financing Activity | 117,024 | 118,248 | 0 | 0 | 394 |
| Financing Cash Flow | $663,233 | $153,115 | $N/A | $N/A | $83,595 |
| Exchange Rate Effect | 117 | 218 | N/A | N/A | -269 |
| Beginning Cash Position | 31,677 | 31,677 | N/A | N/A | 88,157 |
| End Cash Position | 352,932 | 157,034 | N/A | N/A | 31,677 |
| Net Cash Flow | $321,255 | $125,357 | $N/A | $N/A | $-56,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,988 | -26,603 | N/A | N/A | -29,234 |
| Capital Expenditure | -178 | N/A | N/A | N/A | -116 |
| Free Cash Flow | -37,166 | -26,603 | 0 | 0 | -29,350 |